A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants
Clinical trial NCT06083623 · COMPLETED
Trial details
- NCT number
- NCT06083623
- Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2025-06-16
- Enrollment
- 2282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.